Health on MSN6h
Why's It So Hard to Get a GLP-1 Prescription?
However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...
Hosted on MSN7h
What You Need To Know about Compounded Medications
Semaglutide (sold under brand names like Ozempic and Wegovy) and tirzepatide (sold under brand names like Mounjaro and ...
CBS19 News9h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Gwinnett Daily Post9h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
KSJB AM10h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
The Manhattan Mercury11h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southern Minn11h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
Southern Minn11h
Minnesota Has the 13th Lowest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Iosco County News-Herald11h
Michigan Residents Are Using GLP-1s at the 6th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Digital Courier11h
North Carolina Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...